Novorêx · Applied Neurointelligence · About
Why Novorêx exists.
A cancer doctor’s question: what are we missing when we don’t hear the person?
Dr. Sam Sater MD · Hematologist-oncologist and physician-scientist
- Board-certifiedAmerican Board of Internal Medicine: internal medicine, hematology and medical oncology
- NCI · NIHPhysician-scientist and faculty, 2017–2021. Founded its Tumor Immune Microenvironment Laboratory
- 30+ trialsContributed to clinical trials, Phase I–IV
- 20+ yearsPatient care, cancer research and medical education
- MENASA 2026Spoke at the 2nd MENASA Summit, Sugar Land, Texas, September 2026
Our line
Novorêx: humanizing AI to advance human maturation and intelligence. The human layer of care, led by a physician.
“I trained and practiced in some of medicine’s most demanding places. And still, one year, I could not tell who I was anymore. What helped me rebuild was not working harder. It was finally looking at the beliefs that had been driving me for decades. That experience is why Novorêx exists.”
What we work on.
Access
Where you live can change the care you get: how soon you are seen, how far you travel, what it costs.
Novorêx is working toward care that is more equal, wherever people live.
Blind spots
Each of us sees through our own reality. So do teams, clinics and health systems. Some of what we can’t see is harm built into how care is organized.
We design our education and tools to help people and organizations notice it, and talk about it.
The missing layer
Beliefs, values and feelings shape how people live, lead and receive care.
This is the subject of The Missing Layer in Healing, the forthcoming book by Dr. Sam Sater MD.
Dr. Sam Sater MD
Founder of Novorêx · Founder and CEO, HAS Consulting LLC, which operates Novorêx
Dr. Sam Sater MD is a hematologist-oncologist and physician-scientist, board-certified by the American Board of Internal Medicine in internal medicine, hematology and medical oncology.
He has spent more than twenty years in patient care, cancer research and medical education.
From 2017 to 2021 he was a physician-scientist and faculty member at the National Cancer Institute (NIH), where he founded its Tumor Immune Microenvironment Laboratory. He has contributed to more than thirty clinical trials, from Phase I to Phase IV.
In the clinic he saw two people hear the same diagnosis and walk very different roads.
Novorêx is the result: Applied Neurointelligence, led by a physician, so that every person is heard. What Applied Neurointelligence means.
He continues to care for patients with cancer and blood disorders through Dr. Sater Boutique Clinic, a separate practice whose services are offered only at consultdrsater.com.
Selected publications and writing
- Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancerPublication record
- Diagnosis, clinical management, and emerging strategies for coronary artery disease in patients with cancerPublication record
Writing and commentary
- Unlocking the secrets of PD-L1 signalingFind it on nature.com
Speaking and teaching
- 2nd MENASA Summit, Sugar Land, Texas, 1 to 2 September 2026. Conference session title: “Next-Level Personalized Healthcare: Mental Health 2.0, Root-Cause Medicine & AI.”
How we label what we say.
- Established.
Accepted science, from peer-reviewed and replicated work.
- Emerging.
Published, but early or limited. We say so.
- Novorêx model.
Our own frameworks. Educational, not yet formally tested, and not diagnostic or treatment tools.
Start with the first chapter.
Novorêx is a trade name of HAS Consulting LLC. Novorêx Academy is its education arm. Clinical care with Dr. Sam Sater MD is provided by his clinic, separately from Novorêx.
